Sinarest wins AWACS brand of the year for marketing excellence

Our Bureau, MumbaiWednesday, November 20, 2019, 17:10 Hrs  [IST]

Sinarest has won the prestigious brand of the year award for marketing excellence for an unprecedented sixth year in a row at the AWACS Awards held in Mumbai recently.

Introduced in 1983 in India by Centaur Pharmaceuticals, Sinarest is the leader in the prescription anti-cold market for over two decades amid intense competition from international, domestic, regional, OTC and alternate therapy brands.

Brand Sinarest clocked sales of Rs. 300 crores from all its extensions as per the October 2019 AWACS PharmaTrac report registering a robust MAT growth of 13% in the last twelve months.

The national market share of Sinarest is 43% by value and 40% by volumes. Sinarest is freely available with over 7 lakh chemists in India.

Sinarest is the Number 1 prescribed anticold brand across specialities like ENT surgeons, paediatricians, consulting physicians and family physicians. In India, two prescriptions of Sinarest are clocked every second by doctors in India.

Sinarest is also the Number 1 prescribed anticold brand in Uganda and Cambodia.

Says SD Sawant, managing director, Centaur Pharmaceuticals“In India the most important attribute to own in a doctor’s mind is trust. Sinarest has earned the trust of doctors in India by consistently delivering on its promise of efficacy, safety and relief, over the past three decades.”

Sinarest is known for its quality backed by ethical marketing practices based on evolving scientific research and rationale. Sinarest has used innovative digital marketing in collaboration with leading doctors to sensitise patients about the perils of self medication.

The successful Nosipedia digital initiative powered by Sinarest and doctors reached a million patients, resulting in over 1 lakh likes on social media.

Centaur Pharmaceuticals is a US$ 100 million pharmaceutical company with exports to 110 countries. Centaur has a presence across the pharmaceutical value chain with proficiency in API, formulations, clinical research and contract manufacturing.  Centaur is ranked 35th in India by prescriptions and is the world’s third largest and India’s largest manufacturer and exporter of psychotropic API.